Forbes Travel Guide Five-Star Four Seasons Hotel Boston, which overlooks the Boston Public Garden, is a luxurious hotel with an unbeatable location. Coterie, its exquisitely decorated lobby-level ...

Just because it’s winter in Boston doesn’t mean you need to hibernate and stay indoors until spring arrives. From new stage shows to pop music concerts and everything in between, there are ...

Horford has been upgraded from questionable to available Friday after missing Boston's previous two contests due to a sprained left toe. Horford is averaging 6.2 points, 5.0 rebounds, 1.5 assists ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including significant share repurchases and royalty acquisitions NEW YORK, Jan ...

When settling on your new year’s resolutions for 2025, might we suggest adding “try a new Greater Boston restaurant” to the list? Our opening guide is back for another year, and there are ...

“While Royalty Pharma does not generally sell royalty investments, Novartis’ acquisition of MorphoSys created a unique opportunity to convert a fixed stream of long-term payments with no ...

Tonight will have mostly cloudy skies and just the odd clear break in places. Mainly dry but there may be the odd spot of light rain and drizzle locally. Saturday Tomorrow will have a cloudy start ...

1815 Massachusetts Avenue, Cambridge; 70 Pier 4 Boulevard, Suite 260, Boston; yumegaarukara.com Follow New York Times Cooking on Instagram , Facebook , YouTube , TikTok and Pinterest .

MorphoSys has said it will press ahead with regulatory filings for its myelofibrosis drug candidate pelabresib, despite mixed results in a phase 3 trial. The German biotech says it hopes the ...

Online Programs in professional areas with the largest enrollments are evaluated annually by U.S. News, based on criteria such as employment outcomes of graduates. Explore more than 1,900 graduate ...

Incyte and MorphoSys' antibody therapy tafasitamab has been approved in Europe, promising to provide a more convenient alternative to expensive and cumbersome CAR-T therapies for patients with ...